Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
GJAN - FT Vest U.S. Equity Moderate Buffer ETF - January - Stock Price Chart
TickerGJAN [AMEX]
CompanyFT Vest U.S. Equity Moderate Buffer ETF - January
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Quant Strat
IndexSPDR S&P 500 ETF Trust
TagsU.S., options, SP500, buffer, upside-cap, fixed-period
Sector/Theme Region
Dividend-Active/Passive
Total Holdings6AUM286.85M
Flows% 1M-0.92%Flows% 3M0.60%
Flows% YTD141.15%Flows% 1Y
Return% 1Y16.14%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume28.49K52W Range31.03 - 36.35
DMTK - DermTech Inc - Stock Price Chart
TickerDMTK [NASD]
CompanyDermTech Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap12.59MEPS (ttm)-2.69
P/E-EPS this Y34.05%
Forward P/E-EPS next Y12.90%
PEG-EPS past 5Y-
P/S0.80EPS next 5Y-
P/B0.31EPS Q/Q43.65%
Dividend-Sales Q/Q10.58%
Insider Own11.91%Inst Own13.01%
Insider Trans-0.38%Inst Trans-24.11%
Short Float9.71%EarningsMay 14/a
Analyst Recom2.20Target Price2.28
Avg Volume346.51K52W Range0.49 - 3.90
May-14-24 10:55PM DMTK Stock Earnings: DermTech Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:05PM DermTech Reports First-Quarter 2024 Financial Results (Business Wire)
Apr-18-24 04:15PM DermTech to Explore Strategic Alternatives and Implement Restructuring Plan (Business Wire)
Apr-01-24 04:05PM DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-08-24 08:05AM DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology (Business Wire)
Feb-29-24 04:01PM DermTech Reports Fourth-Quarter 2023 Financial Results (Business Wire)
Feb-13-24 08:05AM DermTech Announces Release Date for Fourth-quarter 2023 Financial Results (Business Wire)
Jan-31-24 04:30PM DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations (Business Wire)
Jan-18-24 08:05AM DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types (Business Wire)
Jan-16-24 08:05AM DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay (Business Wire) -8.45%
HIMS - Hims & Hers Health Inc - Stock Price Chart
TickerHIMS [NYSE, RUT]
CompanyHims & Hers Health Inc
CountryUSA
IndustryHousehold & Personal Products
Market Cap4.00BEPS (ttm)-0.02
P/E-EPS this Y253.25%
Forward P/E43.49EPS next Y153.69%
PEG-EPS past 5Y-
P/S4.16EPS next 5Y-
P/B11.58EPS Q/Q199.79%
Dividend-Sales Q/Q45.81%
Insider Own32.29%Inst Own47.18%
Insider Trans-4.18%Inst Trans4.52%
Short Float12.60%EarningsMay 06/a
Analyst Recom1.92Target Price16.56
Avg Volume7.72M52W Range5.65 - 17.16
May-20-24 04:29PM Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs (Investopedia) +27.66%
03:16PM HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections (InvestorPlace)
02:47PM Top Stock Movers Now: Jabil, Norwegian Cruise Line, Hims & Hers Health, and More (Investopedia)
01:05PM Investors await Nvidia earnings, commodities on the rise: Morning Brief (Yahoo Finance Video)
01:04PM Investors eye chip stocks, Palo Alto Networks earnings on tap: Yahoo Finance (Yahoo Finance Video)
12:15PM Heard on the Street: Hims Is Jumping on a Crowded Ozempic Bandwagon (The Wall Street Journal)
11:01AM Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform (The Wall Street Journal)
10:26AM Weight loss: Hims & Hers introduce access to GLP-1 injections (Yahoo Finance Video)
09:30AM Is Hims & Hers Health (HIMS) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
09:00AM Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers (Business Wire)
PNBK - Patriot National Bancorp Inc - Stock Price Chart
TickerPNBK [NASD]
CompanyPatriot National Bancorp Inc
CountryUSA
IndustryBanks - Regional
Market Cap11.46MEPS (ttm)-0.94
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.17EPS next 5Y-
P/B0.26EPS Q/Q57.35%
Dividend-Sales Q/Q12.20%
Insider Own38.31%Inst Own31.17%
Insider Trans0.00%Inst Trans9.44%
Short Float0.14%Earnings-
Analyst Recom3.00Target Price24.00
Avg Volume2.21K52W Range3.20 - 10.06
Aug-11-23 06:00PM Patriot Reports Second Quarter Results (GlobeNewswire)
Jul-21-23 02:45PM Patriot Bank Announces Appointment of Grace Doherty to the Board of Directors (GlobeNewswire)
May-12-23 06:00PM Patriot Reports Break Even First Quarter (GlobeNewswire) -7.29%
Mar-29-23 01:18PM Patriot Bank Announces Promotion of Chief Lending Officer to President & CEO (GlobeNewswire)
Mar-21-23 06:44AM Here's Why Patriot National Bancorp (NASDAQ:PNBK) Has Caught The Eye Of Investors (Simply Wall St.) +7.51%
Mar-07-23 08:30AM Patriot Reports Fourth Quarter 2022 Net Income of $1.8 million, $0.45 per share; Full Year Net Income of $6.2 million, $1.56 per share (GlobeNewswire)
Dec-21-22 05:30PM Patriot National Bancorp Announces Completion of $12 Million Senior Debt Offering (GlobeNewswire)
Nov-20-22 07:23AM Patriot National Bancorp Third Quarter 2022 Earnings: EPS: US$0.59 (vs US$0.34 in 3Q 2021) (Simply Wall St.)
Nov-10-22 05:43PM Patriot Reports Third Quarter 2022 Net Income of $2.3 million, $0.59 per share; continued growth in loans and deposits (GlobeNewswire)
Sep-23-22 04:05PM Patriot Bank elevates leader in payments to Executive Vice President and Chief Payment Officer (GlobeNewswire)
OGEN - Oragenics Inc - Stock Price Chart
TickerOGEN [AMEX]
CompanyOragenics Inc
CountryUSA
IndustryBiotechnology
Market Cap13.75MEPS (ttm)-7.20
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y29.34%
P/S687.68EPS next 5Y-
P/B13.32EPS Q/Q50.11%
Dividend-Sales Q/Q-100.00%
Insider Own11.83%Inst Own3.66%
Insider Trans-0.66%Inst Trans28.33%
Short Float1.09%Earnings-
Analyst Recom1.00Target Price90.00
Avg Volume134.65K52W Range1.00 - 7.74
May-17-24 08:00AM Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine (GlobeNewswire) +42.07%
May-16-24 12:52PM Oragenics to Start Phase 2 Concussion Treatment Drug Trial -- Shares Rise (MT Newswires)
08:00AM Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial (GlobeNewswire)
May-15-24 01:07PM Oragenics: Q1 Earnings Snapshot (Associated Press Finance)
May-07-24 08:00AM Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia (GlobeNewswire) +24.07%
Apr-19-24 05:50PM Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards (Business Wire)
Apr-01-24 09:05AM Oragenics, Inc. Files 10K and Provides Company Update (Business Wire)
Mar-18-24 07:00AM Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion (Business Wire)
Mar-17-24 08:38AM 15 Highest Quality Probiotics For Gut Health (Insider Monkey)
Mar-05-24 07:45AM Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion (Business Wire)
EVMT - Invesco Electric Vehicle Metals Commodity Strategy No K-1 ETF - Stock Price Chart
TickerEVMT [NASD]
CompanyInvesco Electric Vehicle Metals Commodity Strategy No K-1 ETF
CountryUSA
IndustryExchange Traded Fund
CategoryCommodities & Metals - Gold / Metals
Index-
Tagscommodity, futures, metals, electric-vehicles, batteries, lithium, cobalt
Sector/Theme Region
Dividend4.82%Active/Passive
Total Holdings13AUM9.47M
Flows% 1M0.00%Flows% 3M-7.98%
Flows% YTD-7.98%Flows% 1Y
Return% 1Y-3.53%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume3.12K52W Range15.70 - 22.10
FMAY - FT Vest U.S. Equity Buffer ETF - May - Stock Price Chart
TickerFMAY [AMEX]
CompanyFT Vest U.S. Equity Buffer ETF - May
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Quant Strat
IndexSPDR S&P 500 ETF Trust
TagsU.S., options, SP500, buffer, upside-cap, fixed-period
Sector/Theme Region
Dividend-Active/Passive
Total Holdings6AUM577.40M
Flows% 1M3.90%Flows% 3M2.37%
Flows% YTD-2.10%Flows% 1Y
Return% 1Y17.98%Return% 3Y0.07%
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume32.97K52W Range36.76 - 43.73
HDAW - Xtrackers MSCI All World ex US High Dividend Yield Equity ETF - Stock Price Chart
TickerHDAW [NYSE]
CompanyXtrackers MSCI All World ex US High Dividend Yield Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryGlobal or ExUS Equities - Dividend & Fundamental
IndexMSCI ACWI ex-USA High Div Yld Indx
TagsGlobal-ex-U.S., equity, dividend, quality
Sector/Theme Region
Dividend4.84%Active/Passive
Total Holdings353AUM11.80M
Flows% 1M0.00%Flows% 3M0.00%
Flows% YTD0.00%Flows% 1Y
Return% 1Y16.74%Return% 3Y0.05%
Return% 5Y6.77%Return% 10Y
NAV% Expense
Avg Volume1.26K52W Range21.65 - 27.00
Aug-25-22 12:00PM The Search for Higher Yields Isnt Over (ETF.com)
Jun-03-19 06:21PM DWS Group Adds 15 Xtrackers ETFs to TD Ameritrade ETF Market Center Commission-Free Menu (Business Wire)
Jul-11-18 09:00AM Xtrackers Adds 5 ETFs to Schwab ETF OneSource (Business Wire)
Feb-16-18 09:00AM Deutsche Asset Management Lowers Expense Ratio and Changes Underlying Index for High Dividend Yield Equity ETF Suite (Business Wire)
Jan-03-18 10:20AM 13 Xtrackers ETFs Are Now Available on Schwab ETF OneSource (Business Wire)
Sep-01-17 03:03PM Net Asset Value Restatement for Deutsche X-trackers ETF HDAW (Business Wire)
Jul-10-17 09:15AM Deutsche Asset Management Continues to Add ETFs to Schwab ETF OneSource (Business Wire)
Feb-03-17 04:15PM Net Asset Value Restatements for Deutsche X-trackers ETFs (Business Wire)
Jan-04-17 10:30AM Deutsche Asset Management Extends Relationship with Schwab ETF OneSource (Business Wire)
Sep-26-16 04:26PM International ETFs Offer Attractive Yields and Valuations
WIX - Wix.com Ltd - Stock Price Chart
TickerWIX [NASD]
CompanyWix.com Ltd
CountryIsrael
IndustrySoftware - Infrastructure
Market Cap9.35BEPS (ttm)1.12
P/E150.13EPS this Y22.10%
Forward P/E25.30EPS next Y23.90%
PEG4.68EPS past 5Y-
P/S5.82EPS next 5Y32.10%
P/B-EPS Q/Q323.07%
Dividend-Sales Q/Q12.22%
Insider Own3.93%Inst Own85.11%
Insider Trans0.00%Inst Trans3.22%
Short Float2.17%EarningsMay 20/b
Analyst Recom1.55Target Price175.72
Avg Volume604.49K52W Range73.39 - 146.21
May-20-24 05:15PM Wix.com (WIX) Q1 2024 Earnings Call Transcript (Motley Fool) +23.84%
01:04PM Investors eye chip stocks, Palo Alto Networks earnings on tap: Yahoo Finance (Yahoo Finance Video)
11:44AM Stocks to Watch Monday: Li Auto, Nvidia, Palo Alto Networks, Wix (The Wall Street Journal)
11:30AM Why Is Wix (WIX) Stock Soaring Today (StockStory)
11:12AM Why Wix.com Stock Soared to a 52-Week High Today (Motley Fool)
10:26AM Wix Stock Soars as Q1 Earnings Crush Expectations: 5 Key Takeaways (InvestorPlace)
09:30AM Compared to Estimates, Wix.com (WIX) Q1 Earnings: A Look at Key Metrics (Zacks)
07:41AM Website creator Wix.com Q1 profit tops estimates, raises 2024 outlook (Reuters)
07:10AM Stocks look to continue rally, Nvidia earnings loom: Yahoo Finance (Yahoo Finance Video)
07:10AM Wix.com (WIX) Q1 Earnings and Revenues Top Estimates (Zacks)
GNFT - Genfit ADR - Stock Price Chart
TickerGNFT [NASD]
CompanyGenfit ADR
CountryFrance
IndustryBiotechnology
Market Cap198.84MEPS (ttm)-0.63
P/E-EPS this Y152.86%
Forward P/E9.34EPS next Y29.12%
PEG-EPS past 5Y26.89%
P/S6.44EPS next 5Y-
P/B2.67EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own2.90%Inst Own0.15%
Insider Trans0.00%Inst Trans8.59%
Short Float0.18%EarningsMay 14/a
Analyst Recom1.29Target Price10.20
Avg Volume5.73K52W Range2.89 - 4.75
May-14-24 04:10PM GENFIT Reports First Quarter 2024 Financial Information (GlobeNewswire)
Apr-25-24 04:10PM GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023) (GlobeNewswire)
Apr-15-24 04:10PM GENFIT Annual Combined General Meeting of May 22, 2024 Availability of Preparatory Documents (GlobeNewswire)
Apr-05-24 02:00PM GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F (GlobeNewswire)
Apr-04-24 04:10PM GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-29-24 04:10PM GENFIT Announces Revenues and Cash Position as of December 31, 2023 (GlobeNewswire) -7.31%
Jan-15-24 04:10PM GENFIT Announces 2024 Financial Calendar (GlobeNewswire)
Jan-11-24 04:10PM GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial (GlobeNewswire)
Dec-08-23 01:55AM GENFIT Updates 2024 Outlook Following Acceptance of Elafibranor Filings in Primary Biliary Cholangitis (PBC) (GlobeNewswire) +7.34%
Dec-07-23 05:15AM Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC (GlobeNewswire)
12345678910⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.